← back to search

Matteo Renzulli

Azienda Unità Sanitaria Locale Della Romagna · IT
Area of research
Hepatology · Epidemiology
Research interest
Research interests include Hepatocellular Carcinoma Treatment and Prognosis, Liver Disease Diagnosis and Treatment, Liver Disease and Transplantation, and Cholangiocarcinoma and Gallbladder Cancer Studies.
h-index
39
citations
6,032
works
302
NIH funding
primary concept
Medicine
email

Recent publications

Rim enhancement on imaging of pancreatic ductal adenocarcinoma: systematic review and meta-analysis of biological and prognostic values.
2026cited by 0position: contributordoi
Prostatic artery embolization with glue for benign prostatic hyperplasia in elderly patients: three-year results.
2026cited by 0position: contributordoi
Hepatocellular Carcinoma: Imaging Advances in 2024 with a Focus on Magnetic Resonance Imaging.
2025cited by 3position: contributordoi
Cholecystostomy: how to get a safe way to perform a percutaneous biopsy of the pancreatic head.
2025cited by 0position: contributordoi
Superselective Unilateral Embolization of the Sphenopalatine Artery for Severe Posterior Epistaxis: A Prospective Study on the Safety and Efficacy.
2025cited by 0position: contributordoi
Correction: Prostatic artery embolization with glue for benign prostatic hyperplasia in elderly patients: three-year results.
2025cited by 0position: contributordoi
Towards a Simplified and Cost-Effective Diagnostic Algorithm for the Surveillance of Intraductal Papillary Mucinous Neoplasms (IPMNs): Can We Save Contrast for Later?
2024cited by 1position: contributordoi
The Role of Transarterial Embolization Plus Radiotherapy Compared to Radiotherapy or Transarterial Embolization Alone in the Management of Painful Bone Metastases: Results of a Systematic Review.
2024cited by 1position: contributordoi
Serendipitous Transbiliary Portal Venous Access and Dual Embolization to Resolve a Postoperative Biliary Leak.
2024cited by 0position: contributordoi
Repeated Previous Transarterial Treatments Negatively Affect Survival in Patients with Hepatocellular Carcinoma Receiving Sorafenib
Gastroenterology Insights 2024cited by 0position: contributordoi
Personalised management of patients with hepatocellular carcinoma: a multiparametric therapeutic hierarchy concept
The Lancet Oncology 2023cited by 181position: middledoi
The Synergistic Effect of Interventional Locoregional Treatments and Immunotherapy for the Treatment of Hepatocellular Carcinoma.
2023cited by 26position: contributordoi
Role of Etiology in Hepatocellular Carcinoma Patients Treated with Lenvatinib: A Counterfactual Event-Based Mediation Analysis
Cancers 2023cited by 15position: middledoi
Association between anatomic variations of extrahepatic and intrahepatic bile ducts: Do look up!
2023cited by 11position: contributordoi
Role of Etiology in Hepatocellular Carcinoma Patients Treated with Lenvatinib: A Counterfactual Event-Based Mediation Analysis.
2023cited by 11position: contributordoi
5-MTHF enhances the portal pressure reduction achieved with propranolol in patients with cirrhosis: A randomized placebo-controlled trial.
2023cited by 9position: contributordoi
Uterine Artery Embolization for the Treatment of Symptomatic Uterine Fibroids of Different Sizes: A Single Center Experience.
2023cited by 9position: contributordoi
COVID-19: Has the Liver Been Spared?
2023cited by 8position: contributordoi
Machine Learning Pipeline for the Automated Prediction of MicrovascularInvasion in HepatocellularCarcinomas
Applied Sciences 2023cited by 4position: contributordoi
Update of the Bologna Experience in Radioembolization of Intrahepatic cholangiocarcinoma.
2023cited by 3position: contributordoi
Testicular Adrenal Rest Tumors in Congenital Adrenal Hyperplasia: Study of a Cohort of Patients from a Single Italian Center.
2023cited by 1position: contributordoi
Magnetic Resonance Enterography Reinvented: Exploring the Potential of a New Natural Beverage as an Alternative to Polyethylene Glycol Solution
Gastroenterology Insights 2023cited by 1position: contributordoi
Reverse Mirizzi Syndrome.
2023cited by 0position: contributordoi
Co-Infections and Superinfections in COVID-19 Critically Ill Patients Are Associated with CT Imaging Abnormalities and the Worst Outcomes.
2022cited by 26position: contributordoi
An Imaging Overview of COVID-19 ARDS in ICU Patients and Its Complications: A Pictorial Review.
2022cited by 24position: contributordoi
Sarcopenia Predicts Major Complications after Resection for Primary Hepatocellular Carcinoma in Compensated Cirrhosis.
2022cited by 24position: contributordoi
Reliability of extracellular contrast versus gadoxetic acid in assessing small liver lesions using liver imaging reporting and data system v.2018 and European association for the study of the liver criteria
Hepatology 2022cited by 22position: middledoi
The Feasibility of Liver Biopsy for Undefined Nodules in Patients under Surveillance for Hepatocellular Carcinoma: Is Biopsy Really a Useful Tool?
2022cited by 20position: contributordoi
Reliability of extracellular contrast versus gadoxetic acid in assessing small liver lesions using liver imaging reporting and data system v.2018 and European association for the study of the liver criteria.
2022cited by 18position: contributordoi
Automatically Extracted Machine Learning Features from Preoperative CT to Early Predict Microvascular Invasion in HCC: The Role of the Zone of Transition (ZOT).
2022cited by 18position: contributordoi

Grants

No grants ingested yet.

Frequent collaborators

· 57 papers (2019–2026)Rita Golfieri · Azienda USL di Bologna35 papers (2019–2023)Nicolò Brandi · Elsevier, Inc.15 papers (2021–2024) · 14 papers (2019–2024)Francesco Tovoli · Campus Bio Medico University Hospital14 papers (2019–2024)Alessandro Granito · Center for Studying Health System Change11 papers (2019–2024)Fabio Piscaglia · Ludwig-Maximilians-Universität München11 papers (2019–2024)Matteo Cescon · IRCCS Azienda Ospedliero-Universitaria di Bologna Policlinico di Sant'Orsola10 papers (2020–2023)Matteo Ravaioli · Azienda USL di Bologna9 papers (2020–2023) · 9 papers (2019–2024)Giovanni Marasco · University of Bologna6 papers (2020–2022)Maria Adriana Cocozza · Azienda USL di Bologna5 papers (2022–2023) · 5 papers (2024–2026)Anna Maria Ierardi · University of Ferrara4 papers (2020–2020)Giulio Vara · Publons4 papers (2021–2023)Aldo Carnevale · University of Ferrara4 papers (2020–2020) · 4 papers (2020–2021) · 4 papers (2020–2020)Massimo Iavarone · University of Milan3 papers (2019–2022)Antonio Siniscalchi · 3 papers (2021–2022)